BAY 1895344
selective oral ATR kinase inhibitor in Ph. I for adv. solid tumors and lymphomas from HTS and modeling on PI3Kg structure J. Med. Chem., Jun. 5, 2020 Bayer AG, Berlin, DE
Molecules of the Month - June 2020
Molecules of the Month
- MK-5204
- "Compound 6f"
- GS-9688 (selgantolimod)
- JTE-052 (delgocitinib)
- "Compound 10"
- BAY 1895344
- JNJ-53718678
- BAY 1003803
- "Compound 19" (iron-binder)
- "Compound 2"
- "Compound 19"
- BI-0115
- ASP5286
- (R)-CR8